慢性口服普萘洛尔治疗期间血浆中普萘洛尔和4-羟基普萘洛尔的浓度。
Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.
作者信息
Wong L, Nation R L, Chiou W L, Mehta P K
出版信息
Br J Clin Pharmacol. 1979 Aug;8(2):163-7. doi: 10.1111/j.1365-2125.1979.tb05815.x.
Abstract
1 The plasma levels of propranolol and 4-hydroxypropranolol have been measured in 17 hypertensive patients receiving chronic oral therapy with propranolol. 2 The range of plasma propranolol concentrations was from 5.3 to 300 ng/ml, and that of 4-hydroxypropranolol was from 2.1 to 36.0 ng/ml. 3 The mean (+/- s.d.) plasma concentration ratio of 4-hydroxypropranolol to propranolol was 0.130 (+/- 0.005); however, a very wide range was observed with individual values ranging from 0.057 to 0.241. 4 A statistically significant correlation was observed between the plasma concentration of 4-hydroxypropranolol and that of propranolol. 5 Propranolol and 4-hydroxypropranolol plasma concentrations were each significantly, but poorly, correlated with daily propranolol dose. 6 The clinical significance of the results has been discussed.
摘要
已对17名接受普萘洛尔长期口服治疗的高血压患者测定了其血浆中普萘洛尔和4-羟基普萘洛尔的水平。
血浆普萘洛尔浓度范围为5.3至300 ng/ml，4-羟基普萘洛尔的浓度范围为2.1至36.0 ng/ml。
4-羟基普萘洛尔与普萘洛尔的平均（±标准差）血浆浓度比为0.130（±0.005）；然而，观察到个体值范围非常宽，从0.057至0.241。
观察到4-羟基普萘洛尔的血浆浓度与普萘洛尔的血浆浓度之间存在统计学显著相关性。
普萘洛尔和4-羟基普萘洛尔的血浆浓度各自与每日普萘洛尔剂量显著但相关性较差。
已讨论了结果的临床意义。
相似文献
1
Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.慢性口服普萘洛尔治疗期间血浆中普萘洛尔和4-羟基普萘洛尔的浓度。
Br J Clin Pharmacol. 1979 Aug;8(2):163-7. doi: 10.1111/j.1365-2125.1979.tb05815.x.
2
Measurement of propranolol, 4-hydroxypropranolol and propranolol glycol in human plasma.
Res Commun Chem Pathol Pharmacol. 1979 Apr;24(1):3-12.
3
4-Hydroxypropranolol and its glucuronide after single and long-term doses of propranolol.单次及长期服用普萘洛尔后的4-羟基普萘洛尔及其葡糖醛酸苷。
Clin Pharmacol Ther. 1980 Jan;27(1):22-31. doi: 10.1038/clpt.1980.4.
4
Propranolol plasma levels and relief of migraine. Relationship between plasma propranolol and 4-hydroxypropranolol concentrations and clinical effects.
Arch Neurol. 1985 Jan;42(1):46-8. doi: 10.1001/archneur.1985.04060010052015.
5
Effects of cholestyramine and colestipol on the plasma concentrations of propranolol.消胆胺和考来替泊对普萘洛尔血浆浓度的影响。
Br J Clin Pharmacol. 1984 Sep;18(3):337-42. doi: 10.1111/j.1365-2125.1984.tb02473.x.
6
Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.荧光薄层色谱法测定人血浆和尿液中游离及结合的普萘洛尔、萘氧乳酸和对羟基普萘洛尔
J Pharm Sci. 1978 Jun;67(6):826-31. doi: 10.1002/jps.2600670626.
7
A radioreceptor assay for propranolol and 4-hydroxypropranolol.
Clin Pharmacol Ther. 1980 Jul;28(1):32-9. doi: 10.1038/clpt.1980.127.
8
Plasma levels of (+) and (-)-propranolol and 4-hydroxypropranolol after administration of racemic (+/-)-propranolol in man.在人体中给予消旋（±）-普萘洛尔后（+）和（-）-普萘洛尔及4-羟基普萘洛尔的血浆水平。
Br J Clin Pharmacol. 1982 Jul;14(1):79-82. doi: 10.1111/j.1365-2125.1982.tb04937.x.
9
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
Int J Clin Pharmacol Res. 1984;4(1):19-23.
10
Plasma concentrations of propranolol and 4-hydroxypropranolol in man measured by high pressure liquid chromatography.
Life Sci. 1979 Jan 15;24(3):209-17. doi: 10.1016/0024-3205(79)90221-2.
引用本文的文献
1
Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed.常见心血管药物的线粒体效应：好、坏及混合。
Int J Mol Sci. 2022 Nov 7;23(21):13653. doi: 10.3390/ijms232113653.
2
Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy.普萘洛尔可阻断骨肉瘤细胞周期进程，抑制血管生成，并与顺铂为基础的化疗联合抑制异种移植物生长。
Sci Rep. 2022 Sep 8;12(1):15058. doi: 10.1038/s41598-022-18324-3.
3
Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation.非选择性β受体阻滞剂的使用与无肝硬化和失代偿的慢性乙型肝炎患者肝细胞癌之间的关联
Front Pharmacol. 2022 Jan 7;12:805318. doi: 10.3389/fphar.2021.805318. eCollection 2021.
4
Propranolol Targets Hemangioma Stem Cells via cAMP and Mitogen-Activated Protein Kinase Regulation.普萘洛尔通过环磷酸腺苷（cAMP）和丝裂原活化蛋白激酶调节作用靶向血管瘤干细胞。
Stem Cells Transl Med. 2016 Jan;5(1):45-55. doi: 10.5966/sctm.2015-0076. Epub 2015 Nov 16.
5
Morphological Effects Induced In Vitro by Propranolol on Human Erythrocytes.普萘洛尔对人红细胞的体外形态学影响
J Membr Biol. 2015 Aug;248(4):683-93. doi: 10.1007/s00232-015-9780-2. Epub 2015 Feb 28.
6
Pathogenesis of infantile haemangioma.婴儿血管瘤的发病机制。
Br J Dermatol. 2013 Jul;169(1):12-9. doi: 10.1111/bjd.12435.
7
Propranolol potentiates the anti-angiogenic effects and anti-tumor efficacy of chemotherapy agents: implication in breast cancer treatment.普萘洛尔增强化疗药物的抗血管生成作用和抗肿瘤疗效：对乳腺癌治疗的意义。
Oncotarget. 2011 Oct;2(10):797-809. doi: 10.18632/oncotarget.343.
8
Therapeutic drug monitoring of antiarrhythmic agents.抗心律失常药物的治疗药物监测
Clin Pharmacokinet. 1982 Mar-Apr;7(2):125-48. doi: 10.2165/00003088-198207020-00003.
9
Correlation between propranolol in plasma and urine, renin-aldosterone system and blood pressure in essential hypertension.原发性高血压患者血浆与尿液中普萘洛尔、肾素-醛固酮系统及血压之间的相关性
Eur J Clin Pharmacol. 1981;20(4):251-8. doi: 10.1007/BF00618774.
本文引用的文献
1
Relation of propranolol plasma level to beta-blockade during oral therapy.口服治疗期间普萘洛尔血浆水平与β受体阻滞的关系。
Pharmacology. 1972;7(3):178-84. doi: 10.1159/000136287.
2
Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey.大鼠、犬和猴体内普萘洛尔的吸收、分布及排泄研究。
J Pharmacol Exp Ther. 1971 Feb;176(2):302-11.
3
Effect of route of administration on the relationship between -adrenergic blockade and plasma propranolol level.给药途径对β-肾上腺素能阻滞与血浆普萘洛尔水平之间关系的影响。
Clin Pharmacol Ther. 1972 Mar-Apr;13(2):181-5. doi: 10.1002/cpt1972132181.
4
Pharmacology of 4-hydroxypropranolol, a metabolite of propranolol.普萘洛尔的代谢产物4-羟基普萘洛尔的药理学
Br J Pharmacol. 1971 Sep;43(1):222-35. doi: 10.1111/j.1476-5381.1971.tb07171.x.
5
Spuriously low plasma propranolol concentrations resulting from blood collection methods.采血方法导致血浆普萘洛尔浓度假性降低。
Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):535-8. doi: 10.1002/cpt1975185part1535.
6
Studies of the absorption and removal of propranolol in hypertensive patients during therapy.高血压患者治疗期间普萘洛尔吸收与清除情况的研究。
Circulation. 1975 Aug;52(2):313-8. doi: 10.1161/01.cir.52.2.313.
7
Clinical pharmacology of propranolol.普萘洛尔的临床药理学
Circulation. 1975 Jul;52(1):6-15. doi: 10.1161/01.cir.52.1.6.
8
Plasma binding and the affinity of propranolol for a beta receptor in man.
Clin Pharmacol Ther. 1976 Aug;20(2):152-7. doi: 10.1002/cpt1976202152.
9
Fluorometric TLC determination of free and conjugated propranolol, naphthoxylactic acid, and p-hydroxypropranolol in human plasma and urine.荧光薄层色谱法测定人血浆和尿液中游离及结合的普萘洛尔、萘氧乳酸和对羟基普萘洛尔
J Pharm Sci. 1978 Jun;67(6):826-31. doi: 10.1002/jps.2600670626.
10
High-pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxypropranolol in plasma.
J Chromatogr. 1978 May 1;145(3):429-36. doi: 10.1016/s0378-4347(00)81372-9.
Zotero 插件